Top 4 manufacturers in Wilms Tumor Treatment Market
Updated 10:20:14 September 02, 2019
Prof Resear published a new Market report on Wilms Tumor Treatment Market. It present the largest 4 manufacruers in Wilms Tumor Treatment Market. The report is a professional and in-depth study on the current state of the global Wilms Tumor Treatment market with a focus on the Chinese market. The report provides key statistics on market of Wilms Tumor Treatment. It is a valuable source of guidance and direction for companies and individuals interested in Wilms Tumor Treatment industry.
.
Exelixis Inc
See the company profile for Exelixis , Inc . (EXEL) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their ... Aug 30, 2019 · Company Description . Exelixis , Inc . is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. Corporate Profile : Founded in 1994, Exelixis , Inc . (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following early work in model system genetics, we established a broad drug discovery ...
NanoSmart Pharmaceuticals Inc
The mission of NanoSmart Pharmaceuticals is to positively impact patients with cancer and other diseases worldwide by improving the safety and efficacy of existing pharmaceutical products. To achieve this, NanoSmart has developed several patented drug-delivery systems that are able to reformulate already approved cancer drugs to make them safer ... The companies partnered to explore the feasibility of combining NanoValents hybrid polymerized liposomal nanoparticle drug delivery technology with NanoSmart s antinuclear antibody platform. The companies could not be reached for details. NanoSmart Pharmaceuticals Inc . , Laguna... Oncology Pharma Inc . ("ONPH") is a pioneering oncology company dedicated to developing, manufacturing and commercialization of therapeutics. Oncology Pharma signed a letter of intent (includes a word-wide licence and co-development) to colloborate with NanoSmart ® Pharmaceuticals Inc for its "novel" drug delivery vehicle that can target many types of cancer and other diseases.
Recombio SL
RECOMBIO SL is a company that was established in 03/09/2001. Its company status is active and its cif is B83091132. Its economic activity belongs to the CNAE 72 - Scientific research and development. Its SIC is 8731 - Investigación física comercial. According to its business activity, RECOMBIO SL is dedicated to: Ampliacion del objeto social (2013-05-13) La adquisición y venta ... Company profile page for Top Recambios SL including stock price, company news, press releases, executives, board members, and contact information GlobeImmune, Inc., incorporated on June 5, 2002, is a biopharmaceutical company. The Company is focused on developing products for the treatment of cancer and infectious diseases based on its ...
Selvita SA
Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries. We offer drug discovery support at every stage of the early … Year on year Selvita SA had net income fall from a gain of 6.41m to a loss of 106.32k despite a 14.32% increase in revenues from 67.54m to 77.21m. An increase in the cost of goods sold as a percentage of sales from 64.95% to 74.75% was a component in the falling net income despite rising revenues. Company profile page for Selvita SA including stock price, company news, press releases, executives, board members, and contact information.